• Subject: Re: IBM pushing Java
  • From: "Simon Coulter" <shc@xxxxxxxxxxxxxxxxx>
  • Date: Sun, 28 Mar 99 19:10:10 +1100

Hello Roger,

More agreement!  Yikes!  I'm no longer worried about the impending Y2K problem 
-- the world is coming to an 
end.  There will be wars and rumours of wars and when opposing camps meet in 
agreement the four horsemen will 

Simon Coulter.

 FlyByNight Software         AS/400 Technical Specialists       
 Eclipse the competition - run your business on an IBM AS/400.  
 Phone: +61 3 9419 0175      Mobile: +61 0411 091 400           
 Fax:   +61 3 9419 0175      mailto: shc@flybynight.com.au      
 Windoze should not be open at Warp speed.                      

//--- forwarded letter -------------------------------------------------------
> X-Mailer: Microsoft Outlook Express 4.72.3110.1
> MIME-Version: 1.0
> Date: Tue, 23 Mar 99 10:20:21 -0500
> From: "Roger Pence" <rp@rogerpence.com>
> To: MIDRANGE-L@midrange.com
> Reply-To: MIDRANGE-L@midrange.com
> Subject: Re: IBM pushing Java

> >Right, so that's a definite 2 companies that have JAVA apps, out of a
> >possible how many 100's...?
> There are hundreds of currently available Java solutions! Quit being so
> cynical. Geeze, you sound like I used to! Check out:
> http://www.ibm.com/java/community/success-stories.html
> Java isn't a toy browser scripting lanuage. It is being used to deploy
> mission critical, important applications.
> rp

| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com

This thread ...

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].